Article
Advances in acute myeloid leukemia.
BMJ (Clinical research ed.) - 6 Oct 2021
Newell Laura F, Cook Rachel J
Abstract excerpt
Acute myeloid leukemia (AML) is an uncommon but potentially catastrophic diagnosis with historically high mortality rates. The standard of care treatment remained unchanged for decades; however, recent discoveries of molecular drivers of leukemogenesis and disease progression have led to novel therapies for AML. Ongoing research and clinical trials are actively seeking to personalize therapy by identifying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
